Latest News - Business of Medicine

Tuesday, August 29, 2017 | Business of Medicine, Clinical Trials, Movement Disorders, Research and Publications

AstraZeneca and Takeda Strike $400 Million Development Deal for Investigational Parkinson’s Agent

AstraZeneca and Takeda Pharmaceutical Company Limited will jointly develop and commercialize an investigational alpha-synuclein antibody currently in development for the treatment of Parkinson’s…

Read the full story

Monday, November 23, 2015 | Acquisitions and Mergers, Business of Medicine

Pfizer and Allergan to Combine

The boards of directors for Pfizer Inc. and Allergan plc have both unanimously approved, and the companies have entered into, a definitive merger agreement under which Pfizer will combine with Allerga…

Read the full story

Wednesday, October 28, 2015 | Business of Medicine, Earnings and Financials, Healthcare Trends, Research and Publications

Global Multiple Sclerosis Therapeutics Market Expected to Reach $20 Billion by 2024

The global therapeutics market over the next decade for MS is expected to swell to $20 billion at a compound annual growth rate of 1.5 percent, according to a new report. The recently published “Epi…

Read the full story

Thursday, August 21, 2014 | Business of Medicine, Healthcare Trends

Vicodin vex: DEA tightens restrictions on hydrocodone combos

On Friday the US Drug Enforcement Administration (DEA) will move hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. Pure hydrocodone drugs have been list…

Read the full story